Compare EW & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EW | IDXX |
|---|---|---|
| Founded | 1958 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.2B | 57.1B |
| IPO Year | 1999 | 1996 |
| Metric | EW | IDXX |
|---|---|---|
| Price | $82.49 | $548.11 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 9 |
| Target Price | $96.37 | ★ $721.67 |
| AVG Volume (30 Days) | ★ 4.9M | 566.5K |
| Earning Date | 04-23-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 22.59 |
| EPS | 0.66 | ★ 3.47 |
| Revenue | ★ $6,067,600,000.00 | $4,303,702,000.00 |
| Revenue This Year | $13.39 | $10.88 |
| Revenue Next Year | $9.81 | $8.59 |
| P/E Ratio | ★ $123.42 | $153.10 |
| Revenue Growth | ★ 11.55 | 10.42 |
| 52 Week Low | $72.30 | $496.61 |
| 52 Week High | $87.89 | $769.98 |
| Indicator | EW | IDXX |
|---|---|---|
| Relative Strength Index (RSI) | 53.08 | 45.47 |
| Support Level | $81.39 | $544.66 |
| Resistance Level | $82.56 | $595.15 |
| Average True Range (ATR) | 2.47 | 19.64 |
| MACD | -0.02 | -1.74 |
| Stochastic Oscillator | 68.24 | 40.85 |
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.